Us Bancorp \De\ Arcturus Therapeutics Holdings Inc. Transaction History

Us Bancorp \De\

$74.1 Billion
Q1 2025

A detailed history of Us Bancorp \De\ transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 3,393 shares of ARCT stock, worth $40,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,393

Previous 1,064 218.89%

Holding current value

$40,444

Previous $18,000 94.44%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$10.59 - $20.83 $24,664 - $48,513	2,329 Added 218.89%	3,393 $35,000
Q4 2024 Feb 05, 2025	SELL	$14.82 - $25.48 $340 - $586	-23 Reduced 2.12%	1,064 $18,000
Q3 2024 Oct 28, 2024	SELL	$18.08 - $25.38 $1,627 - $2,284	-90 Reduced 7.65%	1,087 $25,000
Q2 2024 Aug 06, 2024	SELL	$24.35 - $44.39 $827 - $1,509	-34 Reduced 2.81%	1,177 $28,000
Q4 2023 Feb 09, 2024	BUY	$17.71 - $32.97 $442 - $824	25 Added 2.11%	1,211 $38,000
Q3 2023 Nov 03, 2023	SELL	$25.44 - $37.35 $1,195 - $1,755	-47 Reduced 3.81%	1,186 $30,000
Q2 2023 Aug 09, 2023	SELL	$23.94 - $32.36 $1,292 - $1,747	-54 Reduced 4.2%	1,233 $35,000
Q1 2023 May 09, 2023	BUY	$14.72 - $23.97 $382 - $623	26 Added 2.06%	1,287 $30,000
Q4 2022 Feb 13, 2023	BUY	$14.14 - $23.06 $7,253 - $11,829	513 Added 68.58%	1,261 $21,000
Q3 2022 Oct 27, 2022	SELL	$13.05 - $22.13 $1,539 - $2,611	-118 Reduced 13.63%	748 $11,000
Q2 2022 Aug 01, 2022	SELL	$12.26 - $31.17 $9,513 - $24,187	-776 Reduced 47.26%	866 $14,000
Q1 2022 May 11, 2022	BUY	$17.64 - $39.57 $2,134 - $4,787	121 Added 7.96%	1,642 $44,000
Q4 2021 Feb 11, 2022	BUY	$34.2 - $47.56 $10,704 - $14,886	313 Added 25.91%	1,521 $57,000
Q3 2021 Nov 10, 2021	SELL	$27.88 - $58.25 $19,906 - $41,590	-714 Reduced 37.15%	1,208 $58,000
Q2 2021 Aug 05, 2021	BUY	$25.79 - $42.11 $3,920 - $6,400	152 Added 8.59%	1,922 $65,000
Q1 2021 Apr 28, 2021	BUY	$38.75 - $86.92 $50,375 - $112,996	1,300 Added 276.6%	1,770 $73,000
Q4 2020 Feb 04, 2021	SELL	$34.61 - $123.66 $5,364 - $19,167	-155 Reduced 24.8%	470 $20,000
Q2 2019 Aug 13, 2019	BUY	$5.78 - $9.79 $3,612 - $6,118	625 New	625 $6,000

Others Institutions Holding ARCT

# of Institutions

166

Shares Held

25.7M

Call Options Held

163K

Put Options Held

173K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $317M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account